Please use this identifier to cite or link to this item:
|Title:||Considerations in the development of in vitro toxicity testing methods intended for regulatory use|
|Authors:||COECKE Sandra; BOWE Gerard; MILCAMPS Anne; BERNASCONI Camilla; BOSTROEM Ann-Charlotte; BORIES Gilles; FORTANER TORRENT Salvador; GINESTE Jean-Michel; GOULIARMOU VARVARA; LANGEZAAL Ingrid; LISKA Roman; MENDOZA EMILIO; MORATH Siegfried; REINA Vittorio; WILK-ZASADNA IWONA; WHELAN Maurice|
|Type:||Articles in periodicals and books|
|Abstract:||It has been demonstrated that the performance of in vitro toxicity testing methods can be seriously affected by variability in the essential components of the method, including the experimental protocol, the test items (chemicals), the test system (the biological models), and the analytical or measurement technique(s) used. Therefore these aspects need careful consideration during the development of in vitro methods if they are to be used in regulatory applications where compliance with quality systems is typically a prerequisite. Concerning the test system, implementation of the basic concepts of Good Cell Culture Practices (GCCP) is essential in the identification and characterisation of the biological model (test system part of the in vitro method). An adequate quality system, preferably Good Laboratory Practice (GLP) together with GCCP leads to overall Good In vitro Method Practices (GIVIM). Additional guidance for test developers will help to ensure that in vitro methods destined for regulatory use will prove to be robust, reliable and ultimately useful for supporting regulatory decisions.|
|JRC Directorate:||Institute for Health and Consumer Protection Historical Collection|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.